These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36442197)

  • 1. Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype.
    Li JG; Blass BE; Praticò D
    J Alzheimers Dis; 2023; 91(1):463-469. PubMed ID: 36442197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full recovery of the Alzheimer's disease phenotype by gain of function of vacuolar protein sorting 35.
    Li JG; Chiu J; Praticò D
    Mol Psychiatry; 2020 Oct; 25(10):2630-2640. PubMed ID: 30733594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retromer complex system in a transgenic mouse model of AD: influence of age.
    Chu J; Praticò D
    Neurobiol Aging; 2017 Apr; 52():32-38. PubMed ID: 28110103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles.
    Li JG; Chiu J; Ramanjulu M; Blass BE; Praticò D
    Mol Neurodegener; 2020 Jan; 15(1):1. PubMed ID: 31964406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Li JG; Praticò D
    PLoS One; 2013; 8(8):e70991. PubMed ID: 23951061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Lauretti E; Craige CP; Praticò D
    J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
    Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
    J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of autophagy by 12/15Lipoxygenase worsens the phenotype of an Alzheimer's disease mouse model with plaques, tangles, and memory impairments.
    Li JG; Chu J; Praticò D
    Mol Psychiatry; 2021 Feb; 26(2):604-613. PubMed ID: 30279460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically modified mice models for Alzheimer's disease.
    Sankaranarayanan S
    Curr Top Med Chem; 2006; 6(6):609-27. PubMed ID: 16712495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein.
    Young JE; Fong LK; Frankowski H; Petsko GA; Small SA; Goldstein LSB
    Stem Cell Reports; 2018 Mar; 10(3):1046-1058. PubMed ID: 29503090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAK-Mediated Signaling Controls Amyloid Beta Overload, Learning and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Saleh B; Srikanth KD; Sneh T; Yue L; Pelech S; Elliott E; Gil-Henn H
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles.
    Li JG; Chu J; Barrero C; Merali S; Praticò D
    Ann Neurol; 2014 Jun; 75(6):851-63. PubMed ID: 24644038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease.
    Ciavardelli D; Silvestri E; Del Viscovo A; Bomba M; De Gregorio D; Moreno M; Di Ilio C; Goglia F; Canzoniero LM; Sensi SL
    Cell Death Dis; 2010 Oct; 1(10):e90. PubMed ID: 21368863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoline Improves Memory Impairment and Reduces Amyloid-β Level and Tau Phosphorylation Through AMPK Activation in the Mouse Alzheimer's Disease Model.
    Liu QF; Kanmani S; Lee J; Kim GW; Jeon S; Koo BS
    J Alzheimers Dis; 2021; 81(2):507-516. PubMed ID: 33814448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.